Skip to main content

Advertisement

Log in

The possible use of stem cells in regenerative medicine: dream or reality?

  • Overview
  • Published:
Langenbeck's Archives of Surgery Aims and scope Submit manuscript

Abstract

Stem cells are one of the most fascinating areas in regenerative medicine today. They play a crucial role in the development and regeneration of human life and are defined as cells that continuously reproduce themselves while maintaining the ability to differentiate into various cell types. Stem cells are found at all developmental stages, from embryonic stem cells that differentiate into all cell types found in the human body to adult stem cells that are responsible for tissue regeneration. The general opinion postulates that clinical therapies based on the properties of stem cells may have the potential to change the treatment of degenerative diseases or important traumatic injuries in the “near” future. We here briefly review the literature in particularly for the liver, heart, kidney, cartilage, and bone regeneration.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Thomson JA, Itskovitz-Eldor J, Shapiro SS et al (1998) Embryonic stem cell lines derived from human blastocysts. Science 282:1145–1147

    Article  CAS  PubMed  Google Scholar 

  2. Rubart M, Field LJ (2006) Cardiac regeneration: repopulating the heart. Annu Rev Physiol 68:29–49

    Article  CAS  PubMed  Google Scholar 

  3. Chen N, Hudson JE, Walczak P et al (2005) Human umbilical cord blood progenitors: the potential of these hematopoietic cells to become neural. Stem Cells 23:1560–1570

    Article  CAS  PubMed  Google Scholar 

  4. Ruhnke M, Nussler AK, Ungefroren H et al (2005) Human monocyte-derived neohepatocytes: a promising alternative to primary human hepatocytes for autologous cell therapy. Transplantation 79:1097–1103

    Article  PubMed  Google Scholar 

  5. Ruhnke M, Ungefroren H, Nussler A et al (2005) Differentiation of in vitro-modified human peripheral blood monocytes into hepatocyte-like and pancreatic islet-like cells. Gastroenterology 128:1774–1786

    Article  CAS  PubMed  Google Scholar 

  6. Takahashi K, Yamanaka S (2006) Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126:663–676

    Article  CAS  PubMed  Google Scholar 

  7. Okita K, Ichisaka T, Yamanaka S (2007) Generation of germline-competent induced pluripotent stem cells. Nature 448:313–317

    Article  CAS  PubMed  Google Scholar 

  8. Yu J, Vodyanik MA, Smuga-Otto K et al (2007) Induced pluripotent stem cell lines derived from human somatic cells. Science 318:1917–1920

    Article  CAS  PubMed  Google Scholar 

  9. Wernig M, Meissner A, Foreman R et al (2007) In vitro reprogramming of fibroblasts into a pluripotent ES-cell-like state. Nature 448:318–324

    Article  CAS  PubMed  Google Scholar 

  10. Lowry WE, Richter L, Yachechko R et al (2008) Generation of human induced pluripotent stem cells from dermal fibroblasts. Proc Natl Acad Sci U S A 105:2883–2888

    Article  CAS  PubMed  Google Scholar 

  11. Park IH, Zhao R, West JA et al (2008) Reprogramming of human somatic cells to pluripotency with defined factors. Nature 451:141–146

    Article  CAS  PubMed  Google Scholar 

  12. Kim JB, Zaehres H, Wu G et al (2008) Pluripotent stem cells induced from adult neural stem cells by reprogramming with two factors. Nature 454:646–650

    Article  CAS  PubMed  Google Scholar 

  13. Carey BW, Markoulaki S, Hanna J et al (2009) Reprogramming of murine and human somatic cells using a single polycistronic vector. Proc Natl Acad Sci U S A 106:157–162

    Article  CAS  PubMed  Google Scholar 

  14. Li W, Wei W, Zhu S et al (2009) Generation of rat and human induced pluripotent stem cells by combining genetic reprogramming and chemical inhibitors. Cell Stem Cell 4:16–19

    Article  PubMed  CAS  Google Scholar 

  15. Levesque JP, Hendy J, Winkler IG et al (2003) Granulocyte colony-stimulating factor induces the release in the bone marrow of proteases that cleave c-KIT receptor (CD117) from the surface of hematopoietic progenitor cells. Exp Hematol 31:109–117

    Article  CAS  PubMed  Google Scholar 

  16. Petit I, Szyper-Kravitz M, Nagler A et al (2002) G-CSF induces stem cell mobilization by decreasing bone marrow SDF-1 and up-regulating CXCR4. Nat Immunol 3:687–694

    Article  CAS  PubMed  Google Scholar 

  17. Francois S, Mouiseddine M, Mathieu N et al (2007) Human mesenchymal stem cells favour healing of the cutaneous radiation syndrome in a xenogenic transplant model. Ann Hematol 86:1–8

    Article  PubMed  Google Scholar 

  18. Gabelein G, Nussler AK, Morgott F et al (2008) Intrasplenic or subperitoneal hepatocyte transplantation to increase survival after surgically induced hepatic failure? Eur Surg Res 41:253–259

    Article  CAS  PubMed  Google Scholar 

  19. Harada K, Higaki S, Hashimoto K et al (2007) Study on the colonoscopic features of GVHD enteritis that developed after hematopoietic stem cell transplantation. Hepatogastroenterology 54:2221–2227

    PubMed  Google Scholar 

  20. Hauger O, Frost EE, van Heeswijk R et al (2006) MR evaluation of the glomerular homing of magnetically labeled mesenchymal stem cells in a rat model of nephropathy. Radiology 238:200–210

    Article  PubMed  Google Scholar 

  21. Inagaki Y, Higashiyama R, Okazaki I (2007) Treatment strategy for liver fibrosis through recruitment and differentiation of bone marrow stem/progenitor cells. Hepatol Res 37:991–993

    Article  PubMed  Google Scholar 

  22. Kawada H, Fujita J, Kinjo K et al (2004) Nonhematopoietic mesenchymal stem cells can be mobilized and differentiate into cardiomyocytes after myocardial infarction. Blood 104:3581–3587

    Article  CAS  PubMed  Google Scholar 

  23. Oyagi S, Hirose M, Kojima M et al (2006) Therapeutic effect of transplanting HGF-treated bone marrow mesenchymal cells into CCl4-injured rats. J Hepatol 44:742–748

    Article  CAS  PubMed  Google Scholar 

  24. Terai S, Yamamoto N, Omori K et al (2002) A new cell therapy using bone marrow cells to repair damaged liver. J Gastroenterol 37(Suppl 14):162–163

    CAS  PubMed  Google Scholar 

  25. Van Laake LW, Van Hoof D, Mummery CL (2005) Cardiomyocytes derived from stem cells. Ann Med 37:499–512

    Article  PubMed  CAS  Google Scholar 

  26. Glanemann M, Gaebelein G, Nussler N et al (2009) Transplantation of monocyte-derived hepatocyte-like cells (NeoHeps) improves survival in a model of acute liver failure. Ann Surg 249:149–154

    Article  PubMed  Google Scholar 

  27. Horwitz EM, Gordon PL, Koo WK et al (2002) Isolated allogeneic bone marrow-derived mesenchymal cells engraft and stimulate growth in children with osteogenesis imperfecta: Implications for cell therapy of bone. Proc Natl Acad Sci U S A 99:8932–8937

    Article  CAS  PubMed  Google Scholar 

  28. Lazarus HM, Koc ON, Devine SM et al (2005) Cotransplantation of HLA-identical sibling culture-expanded mesenchymal stem cells and hematopoietic stem cells in hematologic malignancy patients. Biol Blood Marrow Transplant 11:389–398

    Article  PubMed  Google Scholar 

  29. Hidaka M, Su GN, Chen JK et al (2007) Transplantation of engineered bone tissue using a rotary three-dimensional culture system. In Vitro Cell Dev Biol Anim 43:49–58

    Article  CAS  PubMed  Google Scholar 

  30. Marra KG, Defail AJ, Clavijo-Alvarez JA et al (2008) FGF-2 enhances vascularization for adipose tissue engineering. Plast Reconstr Surg 121:1153–1164

    Article  CAS  PubMed  Google Scholar 

  31. He L, Nan X, Wang Y et al (2007) Full-thickness tissue engineered skin constructed with autogenic bone marrow mesenchymal stem cells. Sci China C Life Sci 50:429–437

    Article  CAS  PubMed  Google Scholar 

  32. Ma PX (2008) Biomimetic materials for tissue engineering. Adv Drug Deliv Rev 60:184–198

    Article  CAS  PubMed  Google Scholar 

  33. Bosetti M, Santin M, Lloyd AW et al (2007) Cell behaviour on phospholipids-coated surfaces. J Mater Sci Mater Med 18:611–617

    Article  CAS  PubMed  Google Scholar 

  34. Liu X, Won Y, Ma PX (2005) Surface modification of interconnected porous scaffolds. J Biomed Mater Res A 74:84–91

    PubMed  Google Scholar 

  35. Tachibana A, Nishikawa Y, Nishino M et al (2006) Modified keratin sponge: binding of bone morphogenetic protein-2 and osteoblast differentiation. J Biosci Bioeng 102:425–429

    Article  CAS  PubMed  Google Scholar 

  36. Ueblacker P, Wagner B, Vogt S et al (2007) In vivo analysis of retroviral gene transfer to chondrocytes within collagen scaffolds for the treatment of osteochondral defects. Biomaterials 28:4480–4487

    Article  CAS  PubMed  Google Scholar 

  37. Lucke M, Wildemann B, Sadoni S et al (2005) Systemic versus local application of gentamicin in prophylaxis of implant-related osteomyelitis in a rat model. Bone 36:770–778

    Article  CAS  PubMed  Google Scholar 

  38. Schmidmaier G, Wildemann B, Bail H et al (2001) Local application of growth factors (insulin-like growth factor-1 and transforming growth factor-beta1) from a biodegradable poly(D, L-lactide) coating of osteosynthetic implants accelerates fracture healing in rats. Bone 28:341–350

    Article  CAS  PubMed  Google Scholar 

  39. Ameen C, Strehl R, Bjorquist P et al (2008) Human embryonic stem cells: current technologies and emerging industrial applications. Crit Rev Oncol Hematol 65:54–80

    Article  PubMed  Google Scholar 

  40. Jensen J, Hyllner J, Bjorquist P (2009) Human embryonic stem cell technologies and drug discovery. J Cell Physiol 219:513–519

    Article  CAS  PubMed  Google Scholar 

  41. Molne J, Bjorquist P, Andersson K et al (2008) Blood group ABO antigen expression in human embryonic stem cells and in differentiated hepatocyte- and cardiomyocyte-like cells. Transplantation 86:1407–1413

    Article  PubMed  CAS  Google Scholar 

  42. Soderdahl T, Kuppers-Munther B, Heins N et al (2007) Glutathione transferases in hepatocyte-like cells derived from human embryonic stem cells. Toxicol In Vitro 21:929–937

    Article  PubMed  CAS  Google Scholar 

  43. Sartipy P, Bjorquist P, Strehl R et al (2007) The application of human embryonic stem cell technologies to drug discovery. Drug Discov Today 12:688–699

    Article  CAS  PubMed  Google Scholar 

  44. Ehnert S, Nussler AK, Lehmann A et al (2008) Blood monocyte-derived neohepatocytes as in vitro test system for drug metabolism. Drug Metab Dispos 36:1922–1929

    Article  CAS  PubMed  Google Scholar 

  45. Vigneau C, Zheng F, Polgar K et al (2006) Stem cells and kidney injury. Curr Opin Nephrol Hypertens 15:238–244

    Article  PubMed  Google Scholar 

  46. Duan Y, Catana A, Meng Y et al (2007) Differentiation and enrichment of hepatocyte-like cells from human embryonic stem cells in vitro and in vivo. Stem Cells 25:3058–3068

    Article  CAS  PubMed  Google Scholar 

  47. Isaikina Y, Kustanovich A, Svirnovski A (2006) Growth kinetics and self-renewal of human mesenchymal stem cells derived from bone marrow of children with oncohematological diseases during expansion in vitro. Exp Oncol 28:146–151

    CAS  PubMed  Google Scholar 

  48. Stagg J (2008) Mesenchymal stem cells in cancer. Stem Cell Rev 4:119–124

    Article  PubMed  Google Scholar 

  49. Strom S, Fisher R (2003) Hepatocyte transplantation: new possibilities for therapy. Gastroenterology 124:568–571

    Article  PubMed  Google Scholar 

  50. Ott M, Schmidt HH, Cichon G et al (2000) Emerging therapies in hepatology: liver-directed gene transfer and hepatocyte transplantation. Cells Tissues Organs 167:81–87

    Article  CAS  PubMed  Google Scholar 

  51. Sokal EM, Smets F, Bourgois A et al (2003) Hepatocyte transplantation in a 4-year-old girl with peroxisomal biogenesis disease: technique, safety, and metabolic follow-up. Transplantation 76:735–738

    Article  PubMed  Google Scholar 

  52. Kobayashi N, Miyazaki M, Fukaya K et al (2000) Treatment of surgically induced acute liver failure with transplantation of highly differentiated immortalized human hepatocytes. Cell Transplant 9:733–735

    CAS  PubMed  Google Scholar 

  53. Nagata H, Ito M, Shirota C et al (2003) Route of hepatocyte delivery affects hepatocyte engraftment in the spleen. Transplantation 76:732–734

    Article  PubMed  Google Scholar 

  54. Mito M, Kusano M, Kawaura Y (1992) Hepatocyte transplantation in man. Transplant Proc 24:3052–3053

    CAS  PubMed  Google Scholar 

  55. Strom SC, Chowdhury JR, Fox IJ (1999) Hepatocyte transplantation for the treatment of human disease. Semin Liver Dis 19:39–48

    Article  CAS  PubMed  Google Scholar 

  56. Aoki T, Koizumi T, Kobayashi Y et al (2005) A novel method of cryopreservation of rat and human hepatocytes by using encapsulation technique and possible use for cell transplantation. Cell Transplant 14:609–620

    Article  PubMed  Google Scholar 

  57. Ringel M, von Mach MA, Santos R et al (2005) Hepatocytes cultured in alginate microspheres: an optimized technique to study enzyme induction. Toxicology 206:153–167

    Article  CAS  PubMed  Google Scholar 

  58. Chan C, Berthiaume F, Nath BD et al (2004) Hepatic tissue engineering for adjunct and temporary liver support: critical technologies. Liver Transpl 10:1331–1342

    Article  PubMed  Google Scholar 

  59. Aurich H, Sgodda M, Kaltwasser P et al (2009) Hepatocyte differentiation of mesenchymal stem cells from human adipose tissue in vitro promotes hepatic integration in vivo. Gut 58:570–581

    Article  CAS  PubMed  Google Scholar 

  60. Aurich I, Mueller LP, Aurich H et al (2007) Functional integration of hepatocytes derived from human mesenchymal stem cells into mouse livers. Gut 56:405–415

    Article  CAS  PubMed  Google Scholar 

  61. Banas A, Teratani T, Yamamoto Y et al (2007) Adipose tissue-derived mesenchymal stem cells as a source of human hepatocytes. Hepatology 46:219–228

    Article  CAS  PubMed  Google Scholar 

  62. Ishii K, Yoshida Y, Akechi Y et al (2008) Hepatic differentiation of human bone marrow-derived mesenchymal stem cells by tetracycline-regulated hepatocyte nuclear factor 3beta. Hepatology 48:597–606

    Article  CAS  PubMed  Google Scholar 

  63. Jones EA, Tosh D, Wilson DI et al (2002) Hepatic differentiation of murine embryonic stem cells. Exp Cell Res 272:15–22

    Article  CAS  PubMed  Google Scholar 

  64. Lysy PA, Smets F, Sibille C et al (2007) Human skin fibroblasts: From mesodermal to hepatocyte-like differentiation. Hepatology 46:1574–1585

    Article  CAS  PubMed  Google Scholar 

  65. Momose Y, Matsunaga T, Murai K et al (2009) Differentiation of monkey embryonic stem cells into hepatocytes and mRNA expression of cytochrome p450 enzymes responsible for drug metabolism: comparison of embryoid body formation conditions and matrices. Biol Pharm Bull 32:619–626

    Article  CAS  PubMed  Google Scholar 

  66. Najimi M, Khuu DN, Lysy PA et al (2007) Adult-derived human liver mesenchymal-like cells as a potential progenitor reservoir of hepatocytes? Cell Transplant 16:717–728

    PubMed  Google Scholar 

  67. Ruhnke M, Ungefroren H, Zehle G et al (2003) Long-term culture and differentiation of rat embryonic stem cell-like cells into neuronal, glial, endothelial, and hepatic lineages. Stem Cells 21:428–436

    Article  PubMed  Google Scholar 

  68. Shen CN, Slack JM, Tosh D (2000) Molecular basis of transdifferentiation of pancreas to liver. Nat Cell Biol 2:879–887

    Article  CAS  PubMed  Google Scholar 

  69. Kobayashi N, Westerman KA, Tanaka N et al (2001) A reversibly immortalized human hepatocyte cell line as a source of hepatocyte-based biological support. Addict Biol 6:293–300

    Article  PubMed  Google Scholar 

  70. Tosh D, Shen CN, Slack JM (2002) Differentiated properties of hepatocytes induced from pancreatic cells. Hepatology 36:534–543

    Article  CAS  PubMed  Google Scholar 

  71. Hengstler JG, Brulport M, Schormann W et al (2005) Generation of human hepatocytes by stem cell technology: definition of the hepatocyte. Expert Opin Drug Metab Toxicol 1:61–74

    Article  CAS  PubMed  Google Scholar 

  72. Nussler A, Konig S, Ott M et al (2006) Present status and perspectives of cell-based therapies for liver diseases. J Hepatol 45:144–159

    Article  CAS  PubMed  Google Scholar 

  73. Anversa P, Rota M, Urbanek K et al (2005) Myocardial aging–a stem cell problem. Basic Res Cardiol 100:482–493

    Article  CAS  PubMed  Google Scholar 

  74. Leri A, Kajstura J, Anversa P (2005) Cardiac stem cells and mechanisms of myocardial regeneration. Physiol Rev 85:1373–1416

    Article  CAS  PubMed  Google Scholar 

  75. Kamihata H, Matsubara H, Nishiue T et al (2001) Implantation of bone marrow mononuclear cells into ischemic myocardium enhances collateral perfusion and regional function via side supply of angioblasts, angiogenic ligands, and cytokines. Circulation 104:1046–1052

    Article  CAS  PubMed  Google Scholar 

  76. Orlic D, Kajstura J, Chimenti S et al (2001) Bone marrow cells regenerate infarcted myocardium. Nature 410:701–705

    Article  CAS  PubMed  Google Scholar 

  77. Erdo F, Buhrle C, Blunk J et al (2003) Host-dependent tumorigenesis of embryonic stem cell transplantation in experimental stroke. J Cereb Blood Flow Metab 23:780–785

    Article  PubMed  Google Scholar 

  78. Min JY, Yang Y, Converso KL et al (2002) Transplantation of embryonic stem cells improves cardiac function in postinfarcted rats. J Appl Physiol 92:288–296

    Article  PubMed  CAS  Google Scholar 

  79. Angelini P, Markwald RR (2005) Stem cell treatment of the heart: a review of its current status on the brink of clinical experimentation. Tex Heart Inst J 32:479–488

    PubMed  Google Scholar 

  80. Segers VF, Lee RT (2008) Stem-cell therapy for cardiac disease. Nature 451:937–942

    Article  CAS  PubMed  Google Scholar 

  81. Yousef M, Schannwell CM, Kostering M et al (2009) The BALANCE Study: clinical benefit and long-term outcome after intracoronary autologous bone marrow cell transplantation in patients with acute myocardial infarction. J Am Coll Cardiol 53:2262–2269

    Article  PubMed  Google Scholar 

  82. Menasche P, Hagege AA, Vilquin JT et al (2003) Autologous skeletal myoblast transplantation for severe postinfarction left ventricular dysfunction. J Am Coll Cardiol 41:1078–1083

    Article  PubMed  Google Scholar 

  83. Hagege AA, Carrion C, Menasche P et al (2003) Viability and differentiation of autologous skeletal myoblast grafts in ischaemic cardiomyopathy. Lancet 361:491–492

    Article  PubMed  Google Scholar 

  84. Menasche P (2005) Stem cells for clinical use in cardiovascular medicine: current limitations and future perspectives. Thromb Haemost 94:697–701

    PubMed  Google Scholar 

  85. Menasche P, Alfieri O, Janssens S et al (2008) The Myoblast Autologous Grafting in Ischemic Cardiomyopathy (MAGIC) trial: first randomized placebo-controlled study of myoblast transplantation. Circulation 117:1189–1200

    Article  PubMed  Google Scholar 

  86. Tse HF, Kwong YL, Chan JK et al (2003) Angiogenesis in ischaemic myocardium by intramyocardial autologous bone marrow mononuclear cell implantation. Lancet 361:47–49

    Article  PubMed  Google Scholar 

  87. Ye L, Haider H, Sim EK (2006) Adult stem cells for cardiac repair: a choice between skeletal myoblasts and bone marrow stem cells. Exp Biol Med (Maywood) 231:8–19

    CAS  Google Scholar 

  88. Cleland JG, Coletta AP, Abdellah AT et al (2007) Clinical trials update from the American Heart Association 2006: OAT, SALT 1 and 2, MAGIC, ABCD, PABA-CHF, IMPROVE-CHF, and percutaneous mitral annuloplasty. Eur J Heart Fail 9:92–97

    Article  CAS  PubMed  Google Scholar 

  89. Murry CE, Soonpaa MH, Reinecke H et al (2004) Haematopoietic stem cells do not transdifferentiate into cardiac myocytes in myocardial infarcts. Nature 428:664–668

    Article  CAS  PubMed  Google Scholar 

  90. Stamm C, Westphal B, Kleine HD et al (2003) Autologous bone-marrow stem-cell transplantation for myocardial regeneration. Lancet 361:45–46

    Article  PubMed  Google Scholar 

  91. Laham RJ, Oettgen P (2003) Bone marrow transplantation for the heart: fact or fiction? Lancet 361:11–12

    Article  PubMed  Google Scholar 

  92. Brodie JC, Humes HD (2005) Stem cell approaches for the treatment of renal failure. Pharmacol Rev 57:299–313

    Article  PubMed  Google Scholar 

  93. Lin F (2006) Stem cells in kidney regeneration following acute renal injury. Pediatr Res 59:74R–78R

    Article  PubMed  Google Scholar 

  94. Ricardo SD, Deane JA (2005) Adult stem cells in renal injury and repair. Nephrology (Carlton) 10:276–282

    Article  Google Scholar 

  95. Oliver JA, Maarouf O, Cheema FH et al (2004) The renal papilla is a niche for adult kidney stem cells. J Clin Invest 114:795–804

    CAS  PubMed  Google Scholar 

  96. Morigi M, Imberti B, Zoja C et al (2004) Mesenchymal stem cells are renotropic, helping to repair the kidney and improve function in acute renal failure. J Am Soc Nephrol 15:1794–1804

    Article  PubMed  Google Scholar 

  97. Kale S, Karihaloo A, Clark PR et al (2003) Bone marrow stem cells contribute to repair of the ischemically injured renal tubule. J Clin Invest 112:42–49

    CAS  PubMed  Google Scholar 

  98. Anglani F, Forino M, Del Prete D et al (2004) In search of adult renal stem cells. J Cell Mol Med 8:474–487

    Article  CAS  PubMed  Google Scholar 

  99. Bates CM, Lin F (2005) Future strategies in the treatment of acute renal failure: growth factors, stem cells, and other novel therapies. Curr Opin Pediatr 17:215–220

    Article  PubMed  Google Scholar 

  100. Hangody L, Vasarhelyi G, Hangody LR et al (2008) Autologous osteochondral grafting–technique and long-term results. Injury 39(Suppl 1):S32–S39

    Article  PubMed  Google Scholar 

  101. Steinwachs MR, Guggi T, Kreuz PC (2008) Marrow stimulation techniques. Injury 39(Suppl 1):S26–S31

    Article  PubMed  Google Scholar 

  102. Salama R, Weissman SL (1978) The clinical use of combined xenografts of bone and autologous red marrow. A preliminary report. J Bone Joint Surg Br 60:111–115

    CAS  PubMed  Google Scholar 

  103. Goel A, Sangwan SS, Siwach RC et al (2005) Percutaneous bone marrow grafting for the treatment of tibial non-union. Injury 36:203–206

    Article  PubMed  Google Scholar 

  104. Marcacci M, Kon E, Moukhachev V et al (2007) Stem cells associated with macroporous bioceramics for long bone repair: 6- to 7-year outcome of a pilot clinical study. Tissue Eng 13:947–955

    Article  CAS  PubMed  Google Scholar 

  105. Raty JK, Lesch HP, Wirth T et al (2008) Improving safety of gene therapy. Curr Drug Saf 3:46–53

    Article  CAS  PubMed  Google Scholar 

  106. Yi Y, Hahm SH, Lee KH (2005) Retroviral gene therapy: safety issues and possible solutions. Curr Gene Ther 5:25–35

    CAS  PubMed  Google Scholar 

  107. Strom SC, Fisher RA, Thompson MT et al (1997) Hepatocyte transplantation as a bridge to orthotopic liver transplantation in terminal liver failure. Transplantation 63:559–569

    Article  CAS  PubMed  Google Scholar 

  108. Fox IJ, Chowdhury JR, Kaufman SS et al (1998) Treatment of the Crigler-Najjar syndrome type I with hepatocyte transplantation. N Engl J Med 338:1422–1426

    Article  CAS  PubMed  Google Scholar 

  109. Bohnen NI, Charron M, Reyes J et al (2000) Use of indium-111-labeled hepatocytes to determine the biodistribution of transplanted hepatocytes through portal vein infusion. Clin Nucl Med 25:447–450

    Article  CAS  PubMed  Google Scholar 

  110. Horslen SP, McCowan TC, Goertzen TC et al (2003) Isolated hepatocyte transplantation in an infant with a severe urea cycle disorder. Pediatrics 111:1262–1267

    Article  PubMed  Google Scholar 

  111. Muraca M, Gerunda G, Neri D et al (2002) Hepatocyte transplantation as a treatment for glycogen storage disease type 1a. Lancet 359:317–318

    Article  PubMed  Google Scholar 

  112. Dhawan A, Mitry RR, Hughes RD et al (2004) Hepatocyte transplantation for inherited factor VII deficiency. Transplantation 78:1812–1814

    Article  PubMed  Google Scholar 

  113. Meyburg J, Hoerster F, Weitz J et al (2008) Use of the middle colic vein for liver cell transplantation in infants and small children. Transplant Proc 40:936–937

    Article  CAS  PubMed  Google Scholar 

  114. Allen KJ, Mifsud NA, Williamson R et al (2008) Cell-mediated rejection results in allograft loss after liver cell transplantation. Liver Transpl 14:688–694

    Article  PubMed  Google Scholar 

  115. Ambrosino G, Varotto S, Strom SC et al (2005) Isolated hepatocyte transplantation for Crigler-Najjar syndrome type 1. Cell Transplant 14:151–157

    Article  PubMed  Google Scholar 

  116. Meyburg J, Das AM, Hoerster F et al (2009) One liver for four children: first clinical series of liver cell transplantation for severe neonatal urea cycle defects. Transplantation 87:636–641

    Article  PubMed  Google Scholar 

  117. Garg NK, Gaur S, Sharma S (1993) Percutaneous autogenous bone marrow grafting in 20 cases of ununited fracture. Acta Orthop Scand 64:671–672

    Article  CAS  PubMed  Google Scholar 

  118. Gan Y, Dai K, Zhang P et al (2008) The clinical use of enriched bone marrow stem cells combined with porous beta-tricalcium phosphate in posterior spinal fusion. Biomaterials 29:3973–3982

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

This work was partially supported by a grant of the BMBF (FKZ 01GN0984).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Andreas Nussler.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ehnert, S., Glanemann, M., Schmitt, A. et al. The possible use of stem cells in regenerative medicine: dream or reality?. Langenbecks Arch Surg 394, 985–997 (2009). https://doi.org/10.1007/s00423-009-0546-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00423-009-0546-0

Keywords

Navigation